Worth the effort? Weighing up the benefit and burden of continuous positive airway pressure therapy for the treatment of obstructive sleep apnoea in chronic tetraplegia
| Autor: | Marnie Graco, Carmel Nicholls, Maree Barnes, J Tolson, Alyssa Rigoni, Bronwyn Stevens, Sally Green, David J Berlowitz, Sandra Henderson |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
030506 rehabilitation medicine.medical_specialty Time Factors medicine.medical_treatment Quadriplegia Interviews as Topic 03 medical and health sciences 0302 clinical medicine Patient satisfaction Ambulatory care Ambulatory Care medicine Humans Outpatient clinic Continuous positive airway pressure Tetraplegia Qualitative Research Spinal Cord Injuries Sleep Apnea Obstructive Continuous Positive Airway Pressure business.industry Sleep apnea General Medicine Middle Aged medicine.disease respiratory tract diseases nervous system diseases Treatment Outcome Mood Neurology Patient Satisfaction Chronic Disease Physical therapy Patient Compliance Female Observational study Neurology (clinical) 0305 other medical science business 030217 neurology & neurosurgery |
| Zdroj: | Spinal Cord. 57:247-254 |
| ISSN: | 1476-5624 1362-4393 |
| DOI: | 10.1038/s41393-018-0210-z |
| Popis: | Mixed methods OBJECTIVES: Continuous positive airway pressure (CPAP) therapy is the recommended treatment for obstructive sleep apnoea (OSA). The aim of this study was to estimate CPAP adherence in people with tetraplegia and OSA, and to explore the barriers and facilitators to CPAP use.Hospital outpatient department in Melbourne, Australia METHODS: People with chronic tetraplegia and OSA were commenced with auto-titrating CPAP and supported for 1 month. Semi-structured interviews were conducted with participants at one month and analysed thematically. CPAP usage was measured at 1, 6 and 12 months, with "adherent" defined as achieving more than 4 h average per night.Sixteen participants completed the study (80% male; mean age 56 (SD = 15)). Mean nightly CPAP use at one month was 3.1 h (SD = 2.5; 38% adherent), and at 6 months and 12 months were 2.6 h (SD = 2.8; 25% adherent) and 2.1 h (SD = 3.2; 25% adherent). The perceived benefit/burden balance strongly influenced ongoing use. Burden attributed to CPAP use was common, and included mask discomfort, and physical and emotional problems. Adherent participants were motivated by the immediate daytime benefits to mood, alertness and sleepiness. There was a tendency to not recognise symptoms of OSA until after they were treated.CPAP use is challenging for people with tetraplegia, who experience substantial burden from using the device. When tolerated, the proximate benefits are substantial. People with tetraplegia need more intensive support for longer to help them overcome the burdens of CPAP and benefit from the treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink